The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Transfer of Gyrometric Systems Limited

9 Jun 2021 07:01

RNS Number : 2359B
Remote Monitored Systems PLC
09 June 2021
 

9 June 2021

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside is now considered to be in the public domain.

 

Remote Monitored Systems plc

("RMS" or the "Company")

Proposed Transfer of Gyrometric Systems Limited

 

The Company announces that it and Braveheart Investment Group plc ("Braveheart") have agreed to return control of Gyrometric Systems Limited ("Gyrometric") to its founders; David Orton, Dr Paul Orton and Dr Janet Poliakoff (the "Founders") by transferring their shares to the Founders for nominal consideration ("Transfer").

Gyrometric has some world class technology and a number of potential opportunities exist to exploit this intellectual property. However, it would have required significant investment over the next 12 months to take advantage of these opportunities. As a consequence, the Boards of RMS and Braveheart have reluctantly concluded that the best approach is to return Gyrometric to its Founders.

Under the terms of the Transfer, the existing shareholders' agreement will be terminated; all loans will be written off (including those from RMS and Braveheart); and RMS and Braveheart will each retain a small shareholding in Gyrometric (15% and 6.43% respectively, reduced from 58% and 19.5% respectively). Following the Transfer, the Founders will together hold 75.1% and Anthony Ferguson, a non-executive director of Gyrometric, will retain 3.47%. The current value of RMS's investment in Gyrometric, including the loans, is around £0.5 million which will now be written off. RMS has also cleared the current liabilities of Gyrometric, which are estimated at around £33,000, to allow the Founders to take the company forward.

Gyrometric had revenues of c.£83k and a loss of c.£105k in the year ended 31 December 2020.

The Transfer is considered to be a related party transaction in accordance with Rule 13 of the AIM Rules for Companies. Accordingly, the Directors of RMS, being Antony Legge, Richard Clarke, Dr. Felicity Sartain and Dr. Gareth Cave, having consulted with the Company's nominated adviser, SP Angel Corporate Finance LLP, consider that the terms of the Transfer are fair and reasonable insofar as the Company's shareholders are concerned.

The Transfer is also deemed to be a fundamental change of business under Rule 15 of the AIM Rules and, as such, is subject to shareholder approval. RMS will be convening a general meeting for early July, to be held immediately before the Company's Annual General Meeting. A circular will be published in due course.

 

- ENDS -

 

ENQUIRIES:

 

Remote Monitored Systems plc

via IFC Advisory

Antony Legge (Executive Chairman)

 

 

 

SP Angel Corporate Finance LLP

+44 20 3470 0470

Nominated Adviser and Joint Broker

 

Stuart Gledhill

 

Caroline Rowe

 

Peterhouse Capital Limited

+44 20 7469 0930

Joint Broker

 

Lucy Williams

 

 

 

IFC Advisory Ltd

+44 20 3934 6630

Graham Herring

 

Zach Cohen

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGGVRRNGMZM
Date   Source Headline
24th Feb 202111:05 amRNSSecond Price Monitoring Extn
24th Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20211:00 pmRNSUpdate on commissioning and board changes
12th Feb 20212:05 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
12th Feb 20211:12 pmRNSResult of General Meeting
12th Feb 20217:00 amRNSGeneral Meeting – Link for webinar
9th Feb 20215:56 pmRNSShareholders’ Questions and Answers
8th Feb 20211:23 pmRNSExercise of Options
1st Feb 20211:08 pmRNSExercise of Options
1st Feb 20217:00 amRNSCommissioning delayed
29th Jan 20217:00 amRNSTotal Voting Rights
27th Jan 20217:00 amRNSNotice of General Meeting
26th Jan 20217:00 amRNSExercise of Options
25th Jan 20213:29 pmRNSExercise of Options
25th Jan 20217:00 amRNSExercise of Warrants
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 202112:56 pmRNSEN14683 Certification, Commissioning Update
22nd Jan 20217:00 amRNSShare Option Grant update
21st Jan 20219:06 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 20217:00 amRNSBoard appointment,update on mask production and GM
11th Jan 20216:26 pmRNSDirector Dealing
11th Jan 20217:00 amRNSBoard changes
8th Jan 20215:00 pmRNSDirector Option Exercise and Total Voting Rights
8th Jan 20217:00 amRNSDirector Option Exercise and Total Voting Rights
7th Jan 202110:52 amRNSStatement regarding share price movement
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20217:00 amRNSPharm 2 Farm Update
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
31st Dec 202011:51 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSPlanned Board Changes & Warrant Update
29th Dec 20207:00 amRNSPharm 2 Farm Update
23rd Dec 20208:13 amRNSUpdate on Fundraising & response to announcements
18th Dec 202011:05 amRNSSecond Price Monitoring Extn
18th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20209:51 amRNSPlacing to raise £5,000,000 and Issue of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.